Development of a TLR7/8 agonist adjuvant formulation to overcome early life hyporesponsiveness to DTaP vaccination.
Dowling DJ, Barman S, Smith AJ, Borriello F, Chaney D, Brightman SE, Melhem G, Brook B, Menon M, Soni D, Schüller S, Siram K, Nanishi E, Bazin HG, Burkhart DJ, Levy O, Evans JT.
Dowling DJ, et al. Among authors: burkhart dj.
Sci Rep. 2022 Oct 18;12(1):16860. doi: 10.1038/s41598-022-20346-w.
Sci Rep. 2022.
PMID: 36258023
Free PMC article.